Department Of Pharmaceutics 1

1. Promising vaccine models against astrovirus MLB2 using integrated vaccinomics and immunoinformatics approaches
2. Are Graphene-Based Nanomaterials Safe for Biomedical Applications?
3. Cu₂ZnGeSe₄ single crystals: Growth, structure and temperature dependence of band gap
4. Growing crystals and studying structure and electronic properties of Cu₂ZnGe(S_хSe_1-x)₄ compositions
5. Retraction notice to Growing crystals and studying structure and electronic properties of Cu₂ZnGe(S_хSe_1-x)₄ compositions (Heliyon, (2023), 9, 11, (e22533), (S2405844023097414), 10.1016/j.heliyon.2023.e22533)
6. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
7. Phytochemicals, Herbal Extracts, and Dietary Supplements for Metabolic Disease Management
8. A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey
9. Exploring stevioside binding affinity with various proteins and receptors actively involved in the signaling pathway and a future candidate for diabetic patients
10. Potential of chimeric antigen receptor (CAR)-redirected immune cells in breast cancer therapies: Recent advances
11. Evaluating the Efficacy of Immunomodulatory Therapies in Rheumatoid Arthritis: A Clinical Study
12. The Re-emergence of Diphtheria Amidst Multiple Outbreaks in Nigeria
13. Identification of avian pathogenic E. coli O (somatic) antigens
14. The Impact of a Psychoeducational Intervention on Illness Perceptions and Self-Care Behaviors in Patients with Atrial Fibrillation
15. The Effects of Herbal Treatments on Post-Delivery Pain
16. Evaluating the Efficacy of Pteris vittata in Arsenic Remediation from Contaminated Soils
17. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
18. Role of Gold Nanoparticles in Inhibiting Amyloid Formation and Reducing Vascular Dementia Risk
1